Adult-Onset Still Disease Market by Therapy
• NSAIDs
• Biologics
• Corticosteroids
• Other

Adult-Onset Still Disease Market- By Region
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Adult-Onset Still Disease Market Snapshot
Chapter 4. Global Adult-Onset Still Disease Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Adult-Onset Still Disease Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on Global Adult-Onset Still Disease Industry Trends
Chapter 5. Global Adult-Onset Still Disease MarketSegmentation 1: By Therapy Type, Estimates & Trend Analysis
5.1. Market Share By Therapy Type, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
5.2.1. Manual Scoop Stretcher
5.2.2. Biologics
5.2.3. Corticosteroids
5.2.4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
5.2.5. Other Therapies
Chapter 6. Global Adult-Onset Still Disease MarketSegmentation 2: Regional Estimates & Trend Analysis
6.1. Global Adult-Onset Still Disease Market, Regional Snapshot 2024 & 2034
6.2. North America
6.2.1. North America Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
6.2.1.1. US
6.2.1.2. Canada
6.2.2. North America Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts By Therapy Type, 2021-2034
6.3. Europe
6.3.1. Europe Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
6.3.1.1. Germany
6.3.1.2. U.K.
6.3.1.3. France
6.3.1.4. Italy
6.3.1.5. Spain
6.3.1.6. Rest of Europe
6.3.2. Europe Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts By Therapy Type, 2021-2034
6.4. Asia Pacific
6.4.1. Asia Pacific Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
6.4.1.1. India
6.4.1.2. China
6.4.1.3. Japan
6.4.1.4. Australia
6.4.1.5. South Korea
6.4.1.6. Hong Kong
6.4.1.7. Southeast Asia
6.4.1.8. Rest of Asia Pacific
6.4.2. Asia Pacific Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts By Therapy Type, 2021-2034
6.5. Latin America
6.5.1. Latin America Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
6.5.1.1. Brazil
6.5.1.2. Mexico
6.5.1.3. Rest of Latin America
6.5.2. Latin America Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts By Therapy Type, 2021-2034
6.6. Middle East & Africa
6.6.1. Middle East & Africa Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
6.6.1.1. GCC Countries
6.6.1.2. Israel
6.6.1.3. South Africa
6.6.1.4. Rest of Middle East and Africa
6.6.2. Middle East & Africa Adult-Onset Still Disease Market Revenue (US$ Million) Estimates and Forecasts By Therapy Type, 2021-2034
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. Novartis AG
7.2.1.1. Business Overview
7.2.1.2. Key Product/Service
7.2.1.3. Financial Performance
7.2.1.4. Geographical Presence
7.2.1.5. Recent Developments with Business Strategy
7.2.2. F. Hoffmann-La Roche Ltd
7.2.3. Swedish Orphan Biovitrum AB
7.2.4. AB2 Bio Ltd
7.2.5. Apollo Therapeutics
7.2.6. AO Generiumerno
7.2.7. Others
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.